NCT02708355View on ClinicalTrials.gov

Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Heartburn
Interventions
DRUG

Esomeprazole 20 mg

Esomeprazole 20 mg banded capsules (22.3 mg esomeprazole magnesium trihydrate)

DRUG

Placebo

Placebo capsules

Trial Locations (2)

73102

Oklahoma Foundation for Digestive Research, Oklahoma City

St. Anthony Hospital - Conference Rooms, Oklahoma City

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02708355 - Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment | Biotech Hunter | Biotech Hunter